Drugs giant AstraZeneca's major setback as bad trial results wipe £10bn from value



ASTRAZENECA investors felt the pain yesterday as a major setback for a key lung cancer treatment wiped nearly £10billion from the company’s market value.

Source: Daily Express :: Finance Feed http://ift.tt/2h6UCgk

Share this

Related Posts

Previous
Next Post »